Large gap with delayed quotes
|
Last quote
10/16/2026
-
02:00:00
|
Bid
10/16/2026 -
13:57:48
|
Bid Volume |
Ask
10/16/2026 -
13:57:48
|
Ask Volume |
|---|---|---|---|---|
|
37.98
+0.05
(
+0.13% )
|
30.00
|
100 |
43.06
|
100 |
Analysis date: 13.10.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.10.2026.
Quality
Very strong
Very strong
Four stars since 13.10.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 14.07.2026 at a price of 33.04.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 02.10.2026.
4wk Rel Perf
1.40%
1.40%
The four-week dividend-adjusted overperformance versus SP500 is 1.40%.
Risk
High
High
The stock has been on the high-sensitivity level since 01.05.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.94%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.40%.
Mkt Cap in $bn
1.52
1.52
With a market capitalization <$2bn, PHIBRO ANIMAL HEALTH is considered a small-cap stock.
G/PE Ratio
1.13
1.13
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
8.88
8.88
The estimated PE is for the year 2029.
LT Growth
8.71%
8.71%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
1.30%
1.30%
The twelve month estimated dividend yield represents 11.57% of earnings forecasts.
Beta
-1
-1
For 1% of index variation, the stock varies on average by -0.01%.
Correlation
0
0
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
11.48
11.48
The value at risk is estimated at USD 11.48. The risk is therefore 31.18%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.03.2024
15.03.2024